Evidence map›Paper›PMID 30690866›Full record

Trial reportJournal of clinical hypertension (Greenwich, Conn.)2019

Effects of sodium intake on postural lightheadedness: Results from the DASH-sodium trial.

Allison W Peng, Lawrence J Appel, Noel T Mueller, Olive Tang, Edgar R Miller, Stephen P Juraschek

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of clinical hypertension (Greenwich, Conn.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Allison W PengThe Johns Hopkins University School of Medicine, The Johns Hopkins Bloomberg School of Public Health, and The Welch Center for Prevention, Epidemiology and Clinical Research, Baltimore, Maryland.ORCID 0000-0002-1801-6815
Lawrence J AppelThe Johns Hopkins University School of Medicine, The Johns Hopkins Bloomberg School of Public Health, and The Welch Center for Prevention, Epidemiology and Clinical Research, Baltimore, Maryland.
Noel T MuellerThe Johns Hopkins University School of Medicine, The Johns Hopkins Bloomberg School of Public Health, and The Welch Center for Prevention, Epidemiology and Clinical Research, Baltimore, Maryland.
Olive TangThe Johns Hopkins University School of Medicine, The Johns Hopkins Bloomberg School of Public Health, and The Welch Center for Prevention, Epidemiology and Clinical Research, Baltimore, Maryland.ORCID 0000-0002-1974-4857
Edgar R MillerThe Johns Hopkins University School of Medicine, The Johns Hopkins Bloomberg School of Public Health, and The Welch Center for Prevention, Epidemiology and Clinical Research, Baltimore, Maryland.
Stephen P JuraschekDivision of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Johns Hopkins University · USBeth Israel Deaconess Medical Center · US

Funding

Zoledronic Acid in Treatment of Osteoporosis in PostmenoM01RR002635 · NCRR · BRIGHAM AND WOMEN'S HOSPITAL · PI WILLIAMS, GORDON H · 1985 to 2008
$48.4M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007309 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI COX, ANDREA L · 1985 to 2019
$43.2M
The DASH-Sodium Trial: Genetic Determinants of ResponseR01HL057114 · NHLBI · DUKE UNIVERSITY · PI SVETKEY, LAURA P · 2002 to 2004
$1.2M
Vitamin D, Subclinical Cardiovascular Disease, and Orthostatic Hypotension in Older AdultsK23HL135273 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI JURASCHEK, STEPHEN P · 2017 to 2021
$1.1M
The Effects of Diet on the Gut Microbiome and Short Chain Fatty AcidsK01HL141589 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI MUELLER, NOEL T · 2018 to 2022
$845k
DIETARY PATTERNS, SODIUM INTAKE, AND BLOOD PRESSUREU01HL057156 · NHLBI · KAISER FOUNDATION RESEARCH INSTITUTE · PI VOLLMER, WILLIAM M · 1997 to 2001
$771k
The Effects of the DASH Diet and Sodium Reduction on Subclinical Cardiac DamageR21HL144876 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI JURASCHEK, STEPHEN P · 2018 to 2019
$263k
DIETARY PATTERNS, ANTIOXIDANTS AND LIPID PEROXIDATIONK08HL003857 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI MILLER, EDGAR RAYMOND · 1998 to 2001
$239k
DIETARY PATTERNS, SODIUM INTAKE, AND BLOOD PRESSUREU01HL057173 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SACKS, FRANK M · 1997 to 2000
$172k
DIETARY PATTERNS, SODIUM INTAKE AND BLOOD PRESSUREU01HL057190 · NHLBI · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI BRAY, GEORGE · 1997 to 2000
$169k
DIETARY PATTERNS, SODIUM INTAKE, AND BLOOD PRESSUREU01HL057114 · NHLBI · DUKE UNIVERSITY · PI SVETKEY, LAURA P · 1997 to 2000
$159k
DIETARY PATTERNS, SODIUM INTAKE AND BLOOD PRESSUREU01HL057139 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI APPEL, LAWRENCE JOHN · 1997 to 2000
$126k
General Clinical Research Center Program of the National Center for Research Resources M01-RR00722General Clinical Research Center Program of the National Center for Research Resources M01-RR02635NCRR NIH HHS M01 RR000722NCRR NIH HHS M01 RR002635NHLBI NIH HHS K01 HL141589NHLBI NIH HHS K08 HL03857-01NHLBI NIH HHS K23 HL135273NHLBI NIH HHS R01 HL057114NHLBI NIH HHS R21 HL144876NHLBI NIH HHS U01 HL057114NHLBI NIH HHS U01-HL57114NHLBI NIH HHS U01-HL57139NHLBI NIH HHS U01-HL57156NHLBI NIH HHS U01-HL57173NHLBI NIH HHS U01-HL57190NIA NIH HHS L30 AG051250NIGMS NIH HHS T32 GM007309
6 · The paper itself

Abstract

Lightheadedness after standing contributes to adverse clinical events, including falls. Recommendations for higher sodium intake to treat postural lightheadedness have not been evaluated in a trial setting. The Dietary Approaches to Stop Hypertension (DASH)-Sodium trial (1998-1999) tested the effects of the DASH diet and sodium reduction on blood pressure (BP). Participants were randomly assigned to DASH or a typical Western diet (control). During either diet, participants ate three sodium levels (50, 100, 150 meq/d at 2100 kcal) in random order for 30-days, separated by 5-day breaks. Participants reported the presence and severity of postural lightheadedness at baseline and after each feeding period. There were 412 participants (mean age 48 years; 57% women; 57% black). Mean baseline SBP/DBP was 135/86 mm Hg; 9.5% reported baseline lightheadedness. Among those consuming the DASH diet, high vs low sodium increased lightheadedness (OR 1.71; 95% CI: 1.01, 2.90; P = 0.047) and severity of lightheadedness (P = 0.02), but did not affect lightheadedness in those consuming the control diet (OR 0.77; 95% CI: 0.46, 1.29; P = 0.32). Among those consuming high vs low sodium in the context of the DASH diet, adults <60 vs ≥60 years old experienced more lightheadedness (P-interaction = 0.04), along with obese vs non-obese adults (P-interaction = 0.01). In the context of the DASH diet, higher sodium intake was associated with more frequent and severe lightheadedness. These findings challenge traditional recommendations to increase sodium intake to prevent lightheadedness.

Indexed as

AdultBlack or African AmericanBlood PressureBlood Pressure DeterminationCase-Control StudiesDietary Approaches To Stop HypertensionDiet, Sodium-RestrictedDiet, WesternDizzinessFemaleHumansHypertensionMaleMiddle AgedSeverity of Illness IndexSodiumSodiumSodium, DietaryDASH dietorthostatic lightheadednesssodiumtrial

Identifiers

PMID30690866
PMCPMC6420359
OpenAlexW2913994366

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.